Pharmaceutical Executive
A look at how to develop a generic drug and the resources FDA supplies to Abbreviated New Drug Application applications.
Vincent Sansone
Advertisement
Articles by Vincent Sansone
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
2
Ultragenyx Shares Drop Following Failed Phase III Clinical Trial
3
What Moments in FDA’s Review Process Should Patients and Providers be Watching Closely?
4
Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTech Partnership, RedHill Acquires Commercialization Rights to Rebyota & Clenpiq
5